BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 8171869)

  • 1. [Insulin-dependent diabetes mellitus:"EURODIAB IDDM Complications Study"--results from the Vienna center].
    Abrahamian H; Hörnlein B; Gurdet C; Willinger C; Zaruba E; Irsigler K
    Wien Klin Wochenschr; 1994; 106(5):136-40. PubMed ID: 8171869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study.
    Diabetologia; 1994 Mar; 37(3):278-85. PubMed ID: 8174842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study.
    Chaturvedi N; Stephenson JM; Fuller JH
    Diabetes Care; 1995 Jun; 18(6):785-92. PubMed ID: 7555504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between plasma sialic acid concentration and microvascular and macrovascular complications in type 1 diabetes: the EURODIAB Complications Study.
    Crook MA; Pickup JC; Lumb PJ; Giorgino F; Webb DJ; Fuller JH;
    Diabetes Care; 2001 Feb; 24(2):316-22. PubMed ID: 11213885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated with macroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: the EURODIAB prospective complications study.
    Engelen L; Schalkwijk CG; Eussen SJ; Scheijen JL; Soedamah-Muthu SS; Chaturvedi N; Fuller JH; Stehouwer CD
    Cardiovasc Diabetol; 2015 May; 14():67. PubMed ID: 26025465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Microvascular and macrovascular complications in children and adolescents with type 1 diabetes mellitus].
    Fröhlich-Reiterer EE; Borkenstein MH
    Wien Med Wochenschr; 2010 Aug; 160(15-16):414-8. PubMed ID: 20812053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic control and complications in Italian people with diabetes treated with continuous subcutaneous insulin infusion.
    Lepore G; Bonfanti R; Bozzetto L; Di Blasi V; Girelli A; Grassi G; Iafusco D; Laviola L; Rabbone I; Schiaffini R; Bruttomesso D;
    Nutr Metab Cardiovasc Dis; 2018 Apr; 28(4):335-342. PubMed ID: 29428572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Physical Activity on Glycemic Control and Prevalence of Cardiovascular Risk Factors in Adults With Type 1 Diabetes: A Cross-sectional Multicenter Study of 18,028 Patients.
    Bohn B; Herbst A; Pfeifer M; Krakow D; Zimny S; Kopp F; Melmer A; Steinacker JM; Holl RW;
    Diabetes Care; 2015 Aug; 38(8):1536-43. PubMed ID: 26015557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent C-peptide levels and microvascular complications in childhood onset type 1 diabetes of long duration.
    Williams KV; Becker DJ; Orchard TJ; Costacou T
    J Diabetes Complications; 2019 Sep; 33(9):657-661. PubMed ID: 31239235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
    Lepore G; Bruttomesso D; Nosari I; Tiengo A; Trevisan R
    Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
    Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
    Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study.
    Tesfaye S; Stevens LK; Stephenson JM; Fuller JH; Plater M; Ionescu-Tirgoviste C; Nuber A; Pozza G; Ward JD
    Diabetologia; 1996 Nov; 39(11):1377-84. PubMed ID: 8933008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study.
    Pettus JH; Zhou FL; Shepherd L; Preblick R; Hunt PR; Paranjape S; Miller KM; Edelman SV
    Diabetes Care; 2019 Dec; 42(12):2220-2227. PubMed ID: 31548241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
    Yang CY; Su PF; Hung JY; Ou HT; Kuo S
    Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relation between QTc interval prolongation and diabetic complications. The EURODIAB IDDM Complication Study Group.
    Veglio M; Borra M; Stevens LK; Fuller JH; Perin PC
    Diabetologia; 1999 Jan; 42(1):68-75. PubMed ID: 10027581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study.
    Sjølie AK; Stephenson J; Aldington S; Kohner E; Janka H; Stevens L; Fuller J
    Ophthalmology; 1997 Feb; 104(2):252-60. PubMed ID: 9052629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The absence of a glycemic threshold for the development of long-term complications: the perspective of the Diabetes Control and Complications Trial.
    Diabetes; 1996 Oct; 45(10):1289-98. PubMed ID: 8826962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relations between diabetic retinopathy and cardiovascular neuropathy--a cross-sectional study in IDDM and NIDDM patients.
    Zander E; Heinke P; Herfurth S; Reindel J; Ostermann FE; Kerner W
    Exp Clin Endocrinol Diabetes; 1997; 105(6):319-26. PubMed ID: 9439926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABC goal achievement predicts microvascular but not macrovascular complications over 6-years in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study.
    Bjornstad P; Maahs DM; Rewers M; Johnson RJ; Snell-Bergeon JK
    J Diabetes Complications; 2014; 28(6):762-6. PubMed ID: 25270733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.